$0.2694
-0.0096[-3.46%]
Last update: 2:33PM Get Real Time Here
Vicarious Surgical
(NYSE:RBOT)Vicarious Surgical Stock (NYSE:RBOT), Analyst Ratings, Price Targets, Predictions
Vicarious Surgical Inc has a consensus price target of $6, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from Piper Sandler, Morgan Stanley, and BTIG on March 5, 2024, December 4, 2023, and November 14, 2023. With an average price target of $0.53 between Piper Sandler, Morgan Stanley, and BTIG, there's an implied 98.00% upside for Vicarious Surgical Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Morgan Stanley
BTIG
Canaccord Genuity
Canaccord Genuity
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Vicarious Surgical
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/05/2024 | RBOT | Buy Now | Vicarious Surgical | $0.27 | 271.26% | Piper Sandler | Adam Maeder | $1.5 → $1 | Maintains | Neutral | Get Alert |
| 12/04/2023 | RBOT | Buy Now | Vicarious Surgical | $0.27 | 122.76% | Morgan Stanley | Patrick Wood | → $0.6 | Initiates | → Equal-Weight | Get Alert |
| 11/14/2023 | RBOT | Buy Now | Vicarious Surgical | $0.27 | — | BTIG | Ryan Zimmerman | — | Downgrade | Buy → Neutral | Get Alert |
| 11/14/2023 | RBOT | Buy Now | Vicarious Surgical | $0.27 | 48.5% | Canaccord Genuity | Caitlin Cronin | $9 → $0.4 | Downgrade | Buy → Hold | Get Alert |
| 05/31/2023 | RBOT | Buy Now | Vicarious Surgical | $0.27 | 3241.33% | Canaccord Genuity | Kyle Rose | $12 → $9 | Maintains | Buy | Get Alert |
| 07/18/2022 | RBOT | Buy Now | Vicarious Surgical | $0.27 | 2498.81% | BTIG | Ryan Zimmerman | $8 → $7 | Maintains | Buy | Get Alert |
| 05/10/2022 | RBOT | Buy Now | Vicarious Surgical | $0.27 | 1756.29% | Piper Sandler | Adam Maeder | $7 → $5 | Maintains | Neutral | Get Alert |
| 03/04/2022 | RBOT | Buy Now | Vicarious Surgical | $0.27 | 4726.36% | Canaccord Genuity | Kyle Rose | $15 → $13 | Maintains | Buy | Get Alert |
| 03/04/2022 | RBOT | Buy Now | Vicarious Surgical | $0.27 | 2498.81% | Piper Sandler | Adam Maeder | $16 → $7 | Downgrade | Overweight → Neutral | Get Alert |
| 01/07/2022 | RBOT | Buy Now | Vicarious Surgical | $0.27 | 5840.14% | Credit Suisse | Matt Miksic | → $16 | Initiates | → Outperform | Get Alert |
| 12/07/2021 | RBOT | Buy Now | Vicarious Surgical | $0.27 | 5468.88% | Cowen & Co. | Joshua Jennings | — | Initiates | → Outperform | Get Alert |
| 11/05/2021 | RBOT | Buy Now | Vicarious Surgical | $0.27 | 5468.88% | Canaccord Genuity | Kyle Rose | — | Initiates | → Buy | Get Alert |
| 10/18/2021 | RBOT | Buy Now | Vicarious Surgical | $0.27 | 5468.88% | BTIG | Ryan Zimmerman | — | Initiates | → Buy | Get Alert |
| 10/07/2021 | RBOT | Buy Now | Vicarious Surgical | $0.27 | 5840.14% | Piper Sandler | Adam Maeder | — | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Vicarious Surgical (RBOT)?
The latest price target for Vicarious Surgical (NYSE: RBOT) was reported by Piper Sandler on March 5, 2024. The analyst firm set a price target for $1.00 expecting RBOT to rise to within 12 months (a possible 271.26% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vicarious Surgical (RBOT)?
The latest analyst rating for Vicarious Surgical (NYSE: RBOT) was provided by Piper Sandler, and Vicarious Surgical maintained their neutral rating.
When was the last upgrade for Vicarious Surgical (RBOT)?
There is no last upgrade for Vicarious Surgical.
When was the last downgrade for Vicarious Surgical (RBOT)?
The last downgrade for Vicarious Surgical Inc happened on November 14, 2023 when BTIG changed their price target from N/A to N/A for Vicarious Surgical Inc.
When is the next analyst rating going to be posted or updated for Vicarious Surgical (RBOT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vicarious Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vicarious Surgical was filed on March 5, 2024 so you should expect the next rating to be made available sometime around March 5, 2025.
Is the Analyst Rating Vicarious Surgical (RBOT) correct?
While ratings are subjective and will change, the latest Vicarious Surgical (RBOT) rating was a maintained with a price target of $1.50 to $1.00. The current price Vicarious Surgical (RBOT) is trading at is $0.27, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.